Maxygen, Inc.

When bluebird bio announced its plans to split into two separately listed entities, analysts were enthusiastic and social media commentators compared it to a different, recently well-received transa

Five Prime Therapeutics Inc. , a company focused on immuno-oncology therapeutics, has appointed its chief operating officer (COO) Aron Knickerbocker as CEO and president – effective Jan. 1, 2017.

The Barcelona-based, privately held mid-sized European pharmaceutical company, Grupo Ferrer Internacional SA , has sweetened its latest move to acquire cash-depleted Alexza Pharmaceuticals Inc.

Ocera Therapeutics, a clinical-stage biopharmaceutical company focused on acute and chronic orphan liver diseases, has promoted Michael Byrnes to chief financial officer. Mr Byrnes has served as vice